Yoshitaka Inoue¹, Nobuaki Nakano², Shigeo Fuji³, Tetsuya Eto⁴, Toshiro Kawakita⁵, Naoyuki Uchida⁶, Junya Kanda⁷, Yoshiko Atsuta⁸, Takahiro Fukuda⁹, Koji Kato¹⁰ (1.Department of Hematology, Kumamoto University Hospital, Kumamoto, Japan, 2.Department of Hematology, Imamura General Hospital, Kagoshima, Japan, 3.Department of Hematology, Osaka International Cancer Institute, Osaka, Japan, 4.Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan, 5.Department of Hematology, Kumamoto Medical Center, Kumamoto, Japan, 6.Department of Hematology, Toranomon Hospital, Tokyo, Japan, 7.Department of Hematology and Oncology, Kyoto University, Kyoto, Japan, 8.Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan, 9.Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan, 10.Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan)

Kodai Kuriyama¹, Shigeo Fuji², Megumi Akiyama³, Koji Iwato⁴, Souichi Shiratori⁵, Yukiyasu Ozawa⁶, Takashi Ashida⁷, Junya Kanda⁸, Takahiro Fukuda⁹, Yoshiko Atsuta¹⁰, Masao Ogata¹¹ (1.Hematol, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan, 2.Hematol., Osaka International Cancer Institute, Osaka, Japan, 3.Hematol., Tokyo Metropolitan Cancer and Infectious Diseases Center, Tokyo, Japan, 4.Hematol., Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan, 5.Hematol., Hokkaido University Hospital, Sapporo, Japan, 6.Hematol., Japanese Red Cross Nagoya First Hospital, Nagoya, Japan, 7.Hematol and Rheumatol., Kindai University Faculty of Medicine, Osaka, Japan, 8.Hematol and Oncol., Kyoto University, Kyoto, Japan, 9.Hematopoietic Stem Cell Transplantation Division, NCCH, Tokyo, Japan, 10.Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan, 11.Hematol., Oita Univ Hospital, Oita, Japan)

Kaito Harada¹, Takayoshi Tachibana², Kazuteru Ohashi³, Yukiyasu Ozawa⁴, Masashi Sawa⁵, Tadakazu Kondo⁶, Jun Ishikawa⁷, Makoto Onizuka¹, Kazunori Imada⁸, Tomoaki Fujisaki⁹, Junji Tanaka¹⁰, Takahiro Fukuda¹¹, Yoshiko Atsuta^12,13, Shinichi Kako¹⁴ (1.Department of Hematology and Oncology, Tokai University, Isehara, Japan, 2.Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan, 3.Hematology Division, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan, 4.Department of Hematology, Japanese Red Cross Nagoya First Hospital, 5.Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan, 6.Department of Hematology, Kyoto University Hospital, Kyoto, Japan, 7.Department of Hematology, Osaka International Cancer Institute, Osaka, Japan, 8.Department of Hematology, Osaka Red Cross Hospital, Osaka, Japan, 9.Department of Internal Medicine, Matsuyama Red Cross Hospital, Matsuyama, Japan, 10.Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan, 11.Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, 12.Japanese Data Center for Hematopoietic Cell Transplantation, 13.Department of Healthcare Administration, Nagoya University, Nagoya, Japan, 14.Division of Hematology, Jichi University, Saitama Medical Center, Saitama, Japan)

Yuki Takeuchi, Fumiya Ohara, Kenta Motegi, Hiroya Wakabayashi, Hirofumi Yokota, Shihomi Kuwano, Hitomi Sawa, Kotaro Miyao, Yuichiro Inagaki, Masashi Sawa (Department of Hematology and Oncology, Anjo Kosei Hospital)

Kenji Kishimoto¹, Daiichiro Hasegawa¹, Kei Irie², Akira Okada³, Akihiro Tamura¹, Nobuyuki Yamamoto¹, Atsuro Saito¹, Aiko Kozaki¹, Toshiaki Ishida¹, Shoji Fukushima², Yoshiyuki Kosaka¹ (1.Hematol. & Oncol., Kobe Children's Hosp., Kobe, Japan, 2.Pharmaceutics, Faculty of Pharmaceutical Science, Kobe Gakuin University, Kobe, Japan, 3.Regulatory Science, Faculty of Pharmacy, Musashino University, Nishitokyo, Japan)